Verition Fund Management LLC Arcturus Therapeutics Holdings Inc. Transaction History
Verition Fund Management LLC
- $20.3 Billion
- Q2 2025
A detailed history of Verition Fund Management LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 63,184 shares of ARCT stock, worth $940,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,184Holding current value
$940,809% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ARCT
# of Institutions
169Shares Held
25.9MCall Options Held
289KPut Options Held
109K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$69.9 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$39.5 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$27.3 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$27.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$27 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $396M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...